News
OncClub
All Oncology News
Pipeline Report
Media
Insights
Medical World News
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Conferences
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Partners
Publications
OncologyLive
Oncology Fellows
Supplements And Featured Publications
All Publications
CME/CE
Resources
Interactive Tools
Learning Modules
Presentations
Sponsored
Subscribe
Print Subscription
eNewsletter

logo
Spotlight
OncClub: Join the Chat on Trending Trials in Cancer
In-person and virtual events just for HCPs
Specialty
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
OncClub
All Oncology News
Pipeline Report
Insights
Medical World News
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Conference Coverage
Conference Listing
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Partners
OncologyLive
Oncology Fellows
Supplements And Featured Publications
All Publications
CME/CE
Interactive Tools
Learning Modules
Presentations
Sponsored
Print Subscription
eNewsletter
Advertisement
Urothelial Cancer
| Breast Cancer
| Lung Cancer
| Gastrointestinal Cancer
| Genitourinary Cancers
| Ovarian Cancer
| Prostate Cancer
| Melanoma & Skin Cancer
| Mantle Cell Lymphoma
| Myeloproliferative Neoplasms
| Biosimilars
| Brain Cancer
| Business Management
| CAR T-cell Therapy
| COVID-19
| Chronic Lymphocytic Leukemia
| Colorectal Cancer
| Disparities in Cancer Care
| Global Oncology
| Gynecologic Oncology
| Head & Neck Cancers
| Hematologic Oncology
| Immuno-Oncology
| Multiple Myeloma
| Neoadjuvant HER2+
| Non-Hodgkin Lymphoma
| Oncology Nursing News
| Pediatric Oncology
| Precision Medicine in Oncology®
| Sarcomas/TGCT
| Supportive Care
View All >>
  • Biosimilars
  • Brain Cancer
  • Breast Cancer
  • Business Management
  • CAR T-cell Therapy
  • COVID-19
  • Chronic Lymphocytic Leukemia
  • Colorectal Cancer
  • Disparities in Cancer Care
  • Gastrointestinal Cancer
  • Genitourinary Cancers
  • Global Oncology
  • Gynecologic Oncology
  • Head & Neck Cancers
  • Hematologic Oncology
  • Immuno-Oncology
  • Lung Cancer
  • Mantle Cell Lymphoma
  • Melanoma & Skin Cancer
  • Multiple Myeloma
  • Myeloproliferative Neoplasms
  • Neoadjuvant HER2+
  • Non-Hodgkin Lymphoma
  • Oncology Nursing News
  • Ovarian Cancer
  • Pediatric Oncology
  • Precision Medicine in Oncology®
  • Prostate Cancer
  • Sarcomas/TGCT
  • Supportive Care
  • Urothelial Cancer

SPOTLIGHT -

OncClub: Join the Chat on Trending Trials in Cancer
| In-person and virtual events just for HCPs

Optimizing Treatment Selection in Liver Cancer

home / peer-exchange / optimizing-liver-cancer
Multidisciplinary Approaches in HCC

EP. 1: Multidisciplinary Approaches in HCC

February 15th 2017
Liver Transplant Candidacy in HCC

EP. 2: Liver Transplant Candidacy in HCC

February 15th 2017
Resection vs Transplant in HCC: Factors to Consider

EP. 3: Resection vs Transplant in HCC: Factors to Consider

February 15th 2017
Radiofrequency Ablation and Curative Intent in HCC

EP. 4: Radiofrequency Ablation and Curative Intent in HCC

February 15th 2017
Locoregional Therapy Options in HCC

EP. 5: Locoregional Therapy Options in HCC

February 15th 2017
HCC: Timing of Locoregional and Systemic Therapies

EP. 6: HCC: Timing of Locoregional and Systemic Therapies

February 15th 2017
Dosing Strategies With Sorafenib in HCC

EP. 7: Dosing Strategies With Sorafenib in HCC

February 15th 2017
Improving Survival in HCC

EP. 8: Improving Survival in HCC

February 15th 2017
Incorporating Regorafenib in the HCC Treatment Landscape

EP. 9: Incorporating Regorafenib in the HCC Treatment Landscape

February 15th 2017
Underlying Cirrhosis in the Second-Line Setting of HCC

EP. 10: Underlying Cirrhosis in the Second-Line Setting of HCC

February 15th 2017
Current Understanding With Biomarkers in HCC

EP. 11: Current Understanding With Biomarkers in HCC

February 15th 2017
Emerging c-MET Inhibitors in HCC

EP. 12: Emerging c-MET Inhibitors in HCC

February 15th 2017
Emerging Multikinase Inhibitors in HCC

EP. 13: Emerging Multikinase Inhibitors in HCC

February 15th 2017
Evidence With Checkpoint Inhibition in HCC

EP. 14: Evidence With Checkpoint Inhibition in HCC

February 15th 2017
The Future of HCC Treatment

EP. 15: The Future of HCC Treatment

February 15th 2017

Latest Conference Coverage

Further Understanding of Immune Mechanisms in Tumor Microenvironment Is Key to Advancing Immunotherapy in Solid Tumors

Navigating Systemic Therapy for RCC: Balancing Risk Status and Response

ADCs, Novel Targets Represent Next Wave of Treatment Advances in mCRPC

Precision Medicine in Prostate Cancer Care: Keeping Up With Evolving Guidance for Testing and Decision Making

View More Latest Conference Coverage
Advertise
About OncLive
Editorial Board
CancerNetwork.com
CGTlive.com
CureToday.com
OncNursingNews.com
TargetedOnc.com
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777

© 2023 MJH Life Sciences

All rights reserved.
Home
About Us
News
Contact